Research Analysts Offer Predictions for ISRG FY2025 Earnings

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Analysts at William Blair lifted their FY2025 earnings per share (EPS) estimates for shares of Intuitive Surgical in a report issued on Wednesday, October 22nd. William Blair analyst B. Vazquez now anticipates that the medical equipment provider will earn $7.02 per share for the year, up from their previous estimate of $6.51. The consensus estimate for Intuitive Surgical’s current full-year earnings is $6.43 per share. William Blair also issued estimates for Intuitive Surgical’s Q4 2025 earnings at $1.89 EPS, Q1 2026 earnings at $1.72 EPS, Q2 2026 earnings at $2.02 EPS, Q3 2026 earnings at $2.10 EPS, Q4 2026 earnings at $2.24 EPS and FY2026 earnings at $8.07 EPS.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. During the same period in the prior year, the firm posted $1.84 EPS.

Several other analysts have also issued reports on the company. Jefferies Financial Group increased their target price on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. The Goldman Sachs Group reduced their target price on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a report on Wednesday, October 1st. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Finally, Robert W. Baird set a $655.00 target price on Intuitive Surgical in a report on Wednesday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $603.38.

Intuitive Surgical Stock Performance

ISRG opened at $551.25 on Monday. The firm has a market cap of $197.61 billion, a P/E ratio of 72.92, a price-to-earnings-growth ratio of 5.02 and a beta of 1.61. Intuitive Surgical has a 52-week low of $425.00 and a 52-week high of $616.00. The business’s fifty day moving average is $459.49 and its 200-day moving average is $497.31.

Insiders Place Their Bets

In related news, Director Craig H. Barratt sold 2,193 shares of the company’s stock in a transaction on Friday, October 24th. The stock was sold at an average price of $548.01, for a total transaction of $1,201,785.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director owned 739 shares of the company’s stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 88,324 shares of company stock valued at $46,093,939 in the last quarter. Corporate insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

Large investors have recently bought and sold shares of the company. Chilton Capital Management LLC raised its position in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Tobam raised its position in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares during the last quarter. Elite Financial Inc. bought a new position in Intuitive Surgical in the first quarter valued at about $26,000. Kilter Group LLC bought a new position in Intuitive Surgical in the second quarter valued at about $27,000. Finally, LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical in the first quarter valued at about $30,000. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.